eHealth (EHTH) Form 4: Beth Brooke Awarded Quarterly-Vesting RSUs
Rhea-AI Filing Summary
eHealth, Inc. (EHTH) filed a Form 4 disclosing that independent director Beth A. Brooke received an annual equity grant of 34,574 restricted stock units (RSUs) on 17 June 2025. Each RSU represents one share of common stock and was issued at $0 cost under the company’s 2024 Equity Incentive Plan. The RSUs vest in four equal quarterly installments beginning on the grant date, with accelerated vesting in full either the day before the next annual shareholder meeting or upon a Change-in-Control, contingent on continued service. After the grant, Brooke’s beneficial ownership increased to 132,833 directly held shares. No derivative transactions were reported. The filing reflects routine non-employee director compensation and does not signal any strategic change or material impact on the company’s capital structure.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine RSU grant to director; negligible dilution; neutral governance signal.
The Form 4 shows a standard annual equity award to non-employee director Beth A. Brooke—34,574 RSUs vesting quarterly, with customary acceleration clauses. Such issuances are common practice to align board interests with shareholders and have minimal impact on share count or control dynamics. The grant raises her ownership to 132,833 shares, a modest stake relative to eHealth’s total shares outstanding (not provided here). No 10b5-1 plan or sale transactions are indicated, and the exercise price is $0, confirming it is an outright award rather than an option. Overall, the filing is informational, carries no immediate earnings or cash-flow implications, and should be viewed as neutral from an investor‐impact standpoint.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 34,574 | $0.00 | -- |
Footnotes (1)
- [object Object]